Altimmune, Inc. (ALT)

4.54 +0.32 (+7.46%) USD  |  NASDAQ  |  Jan 21, 15:47
More

Altimmune Tobin's Q (Approximate) (Quarterly)

Tobin's Q (Approximate) (Quarterly) Chart

View Tobin's Q (Approximate) (Quarterly) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Tobin's Q (Approximate) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years

View Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Tobin's Q (Approximate) (Quarterly) Benchmarks

View Tobin's Q (Approximate) (Quarterly) Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Seres Therapeutics, Inc. Upgrade